Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Axillary Management After Neoadjuvant Chemotherapy: May Axillary Biopsy Replace Sentinel Lymph Node Biopsy?

NCT06096545 is registered in ClinicalTrials.gov with Medipol University as lead sponsor.

NCT NCT06096545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06096545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Axillary Management After Neoadjuvant Chemotherapy: May Axillary Biopsy Replace Sentinel Lymph Node Biopsy?
Lead sponsor
Medipol University
Phase
Not applicable
Overall status
Unknown status
Start date
March 12, 2024
Completion date
August 15, 2024
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female, breast neoplasms